Found: 23
Select item for more details and to access through your institution.
Author Index.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 2, p. 273, doi. 10.1111/epi.17389
- Publication type:
- Article
Abstracts.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 2, p. 4, doi. 10.1111/epi.17388
- Publication type:
- Article
14th European Epilepsy Congress Geneva, Switzerland | 9‐13 July 2022 Satellite Symposia Abstracts.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 2, p. 1, doi. 10.1111/epi.17387
- Publication type:
- Article
Epilepsia – February 2022 – Announcements.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 2, p. 510, doi. 10.1111/epi.17170
- Publication type:
- Article
Survey on the worldwide availability and affordability of antiseizure medications: Report of the ILAE Task Force on Access to Treatment.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 2, p. 335, doi. 10.1111/epi.17155
- By:
- Publication type:
- Article
Mutations associated with epileptic encephalopathy modify EAAT2 anion channel function.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 2, p. 388, doi. 10.1111/epi.17154
- By:
- Publication type:
- Article
Association between antiseizure medications and quality of life in epilepsy: A mediation analysis.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 2, p. 440, doi. 10.1111/epi.17153
- By:
- Publication type:
- Article
Early alterations of the neuronal network processing whisker‐related sensory signal during absence epileptogenesis.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 2, p. 497, doi. 10.1111/epi.17151
- By:
- Publication type:
- Article
Norwegian population‐based study of long‐term effects, safety, and predictors of response of vagus nerve stimulation treatment in drug‐resistant epilepsy: The NORPulse study.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 2, p. 414, doi. 10.1111/epi.17152
- By:
- Publication type:
- Article
Long‐term cannabidiol treatment for seizures in patients with tuberous sclerosis complex: An open‐label extension trial.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 2, p. 426, doi. 10.1111/epi.17150
- By:
- Publication type:
- Article
Not your usual drug‐drug interactions: Monoclonal antibody–based therapeutics may interact with antiseizure medications.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 2, p. 271, doi. 10.1111/epi.17147
- By:
- Publication type:
- Article
Correcting for physiological ripples improves epileptic focus identification and outcome prediction.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 2, p. 483, doi. 10.1111/epi.17145
- By:
- Publication type:
- Article
ILAE clinical practice recommendations for the medical treatment of depression in adults with epilepsy.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 2, p. 316, doi. 10.1111/epi.17140
- By:
- Publication type:
- Article
"Do I still have epilepsy?" Epilepsy identity 15–20 years after anterior temporal lobectomy.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 2, p. 402, doi. 10.1111/epi.17143
- By:
- Publication type:
- Article
Accelerated long‐term forgetting in adult patients with genetic generalized epilepsy.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 2, p. 474, doi. 10.1111/epi.17144
- By:
- Publication type:
- Article
Abnormal functional connectivity profiles predict drug responsiveness in patients with temporal lobe epilepsy.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 2, p. 463, doi. 10.1111/epi.17142
- By:
- Publication type:
- Article
Genetic testing for the epilepsies: A systematic review.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 2, p. 375, doi. 10.1111/epi.17141
- By:
- Publication type:
- Article
Increased expression of complement components in tuberous sclerosis complex and focal cortical dysplasia type 2B brain lesions.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 2, p. 364, doi. 10.1111/epi.17139
- By:
- Publication type:
- Article
Relative importance of clinical outcomes and safety risks of antiseizure medication monotherapy for patients and physicians: Discrete choice experiment eliciting preferences in real‐world study "VOTE".
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 2, p. 451, doi. 10.1111/epi.17137
- By:
- Publication type:
- Article
Influences on the trajectory and subsequent outcomes in CDKL5 deficiency disorder.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 2, p. 352, doi. 10.1111/epi.17125
- By:
- Publication type:
- Article
Antiseizure medications and thyroid hormone homeostasis: Literature review and practical recommendations.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 2, p. 259, doi. 10.1111/epi.17117
- By:
- Publication type:
- Article
Minimum standards for inpatient long‐term video‐electroencephalographic monitoring: A clinical practice guideline of the International League Against Epilepsy and International Federation of Clinical Neurophysiology.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 2, p. 290, doi. 10.1111/epi.16977
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 2, p. i, doi. 10.1111/epi.16558
- Publication type:
- Article